Search results
YolTech doses first subject in Phase I trial for YOLT-201 therapy
Clinical Trials Arena· 1 day agoChina-based YolTech Therapeutics has dosed the first patient as part of its Phase I clinical trial...
Sirnaomics concludes second cohort of Phase I RNAi therapeutic trial
Clinical Trials Arena· 5 days agoSirnaomics has concluded the second cohort of its Phase I clinical trial of small interfering RNA...
Spur Therapeutics to begin Phase III gene therapy trial in Gaucher disease
Clinical Trials Arena· 4 days agoThe GALILEO-1 trial is investigating FLT201, an adeno-associated virus (AAV) gene therapy candidate,...
Impact of AI on metabolic disorder clinical trials
Clinical Trials Arena· 2 days agoIt is one of the only clinical trials set to complete in 2026. Similarly, GUB-002496’s clinical trial was also recently initiated, and ...
IDEAYA Biosciences reports positive data from Phase II trial of cancer treatment
Clinical Trials Arena· 4 days agoIn addition, the trial saw a circulating tumour DNA molecular response rate of 81% among...
Zhiyi Biotech reports positive Phase I results for SK10 in CID treatment
Clinical Trials Arena· 5 days agoGuangzhou Zhiyi Biotechnology (Zhiyi Biotech) has reported positive data from the Phase I clinical ...
Epsilogen obtains MHRA approval for Phase Ib trial of ovarian cancer treatment
Clinical Trials Arena· 5 days agoThe trial...ovarian, endometrial, lung, and triple-negative breast cancer, have FR alpha on them....
CalciMedica begins patient dosing in Phase II trial of Auxora for AKI
Clinical Trials Arena· 3 days agotrial for acute pancreatitis (AP) with accompanying systemic inflammatory response syndrome (SIRS),...
uniQure’s shares soar on positive data for Huntington’s gene therapy
Clinical Trials Arena· 22 hours agouniQure’s share price has more than doubled following positive interim data from two Phase I/II...
Interius BioTherapeutics receives approval for B-cell malignancy therapy trial
Clinical Trials Arena· 4 days agoUS-based biotechnology company Interius BioTherapeutics has received approval to begin a Phase I ...